Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NAPROXEN vs NAVITOCLAX: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NAPROXEN vs NAVITOCLAX: Safety Overview

Metric NAPROXEN NAVITOCLAX
Total FAERS Reports 52,751 173
Deaths Reported 5,127 48
Death Rate 9.7% 27.7%
Hospitalizations 12,849 119
Average Patient Age 55.0 yrs 40.5 yrs
% Female Patients 71.5% 35.0%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Aurobindo Pharma Limited N/A
Route ORAL N/A
Marketing Status Discontinued N/A